Anna Doab|Carla Treloar|Gregory J. Dore
Knowledge and Attitudes about Treatment for Hepatitis C Virus Infection and Barriers to Treatment among Current Injection Drug Users in Australia
National Centre for Clinical Research on Emerging Drugs|National Centre for Clinical Research on Emerging Drugs|UNSW Sydney|National Centre for Clinical Research on Emerging Drugs
despite recent improvements outcomes treatment infection hepatitis c virus hcv current injection drug users idus access treatment programs examined natural history treatment knowledge hcv infection barriers willingness seek treatment hcv infection convenience sample current idus n 100 selfreported hcvpositive status drawn primary health facility methadone clinic inner sydney completed intervieweradministered questionnaire participants reasonable knowledge natural history hcv infection poorer knowledge treatment hcv infection believed current idu exclusion criterion treatment despite 7080 idus reported would consider treatment current scenarios australia requirement liver biopsy subcutaneous injections common adverse effects 40 efficacy study participants methadone clinic higher levels consideration treatment findings support development specific education programs regarding treatment hcv infection current idus